01 316BOEHRINGER INGELHEIM
01 1610258637*PED
02 410596120*PED
03 410610489*PED
04 211033552*PED
05 1611090323*PED
06 67407955
07 67407955*PED
08 167579449
09 167579449*PED
10 167713938
11 167713938*PED
12 88551957
13 88551957*PED
14 28673927
15 28673927*PED
16 68883805
17 68883805*PED
18 49155705
19 29173859
20 49415016
21 209949997
22 129949998
23 410022379
24 1610258637
25 410406172
26 1610596120
27 410610489
28 211033552
29 1611090323
30 311564886
31 111666590
32 611813275
33 3211833166
34 109949997*PED
35 109949998*PED
01 38Y
02 278Blank
01 77Y
02 239Blank
01 62025-05-02
02 62025-11-02
03 62025-11-26
04 62026-05-26
05 162027-04-15
06 62027-05-04
07 162027-10-15
08 42027-11-04
09 162028-08-01
10 162029-02-01
11 82029-04-02
12 82029-10-14
13 82030-04-14
14 42030-05-21
15 42030-06-15
16 42030-09-30
17 42031-03-30
18 192032-03-07
19 42032-09-07
20 712034-04-03
21 202034-05-17
22 122034-06-11
23 322034-10-03
24 102034-11-17
25 102034-12-11
Patent Expiration Date : 2027-05-04
US Patent Number : 9173859
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1772
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2029-10-14
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1651
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2034-06-11
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 206073
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-06-11
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-06-11
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-06-11
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-05-17
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-2292
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
LOOKING FOR A SUPPLIER?
